SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
MAXY - Maxygen, Inc.
An SI Board Since December 1999
Posts SubjectMarks Bans Symbol
262 30 0 MAXY
Emcee:  westpacific Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
212Codexis Advances Proprietary Directed Evolution Platform; Custom Biocatalyst Pronigel bates-2/20/2007
211Codexis Introduces Codex(TM) Biocatalyst Panels Monday February 12, 8:31 am ET Nnigel bates-2/12/2007
210Maxygen Reports Fourth Quarter and Year End 2006 Financial Results Tuesday Februnigel bates-2/6/2007
209The way MRK talked about GlycoFi on today’s annual business review, with a few wDewDiligence_on_SI-12/12/2006
208Interesting point. Same is true of epogen, priced out of a lot of markets, despirkrw-12/5/2006
207<i>Novo's F7 can clearly be improved</i> The main thing wrong wDewDiligence_on_SI-12/5/2006
206One thing for sure is it's very difficult to prove statistical superiority orkrw-12/5/2006
205Maxy Alpha is an interesting one. My hypothetical thought is can they get superirkrw-12/5/2006
204All I've ever heard about multi-peg'd gcsf is that is might shorten neutkeokalani'nui-12/5/2006
203I want to add Maxy Alpha apart from Maxy G34 to my wish list of promising progradr.praveen-12/5/2006
202maxy spinouts have done quite well even better than maxy perhaps. What were therrkrw-12/5/2006
201Maxygen Announces Grant of Biofuels License to Codexis, Inc. Tuesday December 5,nigel bates-12/5/2006
200Maxygen's Next-Generation Interferon Alpha Enters Phase Ia Clinical Trial Tunigel bates-11/7/2006
199Maxygen Reports Third Quarter 2006 Financial Results Monday October 30, 7:00 am nigel bates-10/30/2006
198Maxygen to Receive $17.8 Million From Acquisition of Avidia by Amgen Friday Octonigel bates-10/27/2006
197gtcb is trying to be equivalent to novo seven and come in at a lower price, maxyrkrw-10/4/2006
196New (very early) competitor in recombinant Factor VIIa: investorshub.comDewDiligence_on_SI-10/4/2006
195Codexis Initiates Direct Sales of Generic Pharmaceutical Intermediates Tuesday Onigel bates-10/3/2006
194Almost getting interesting. :-)nigel bates-9/16/2006
193New picture of the pipeline:-) maxygen.com 2nd compound supposed to go into thdr.praveen-9/15/2006
192Was for quite a while, then got disillusioned. Still watching though, and may rnigel bates-9/5/2006
191Great news atlast nigel...Feels like one of my bio's hit a P3 endpoint :-) dr.praveen-9/5/2006
190Maxygen Initiates Phase I Clinical Trial for Maxy-G34 Tuesday September 5, 7:00 nigel bates-9/5/2006
189Codexis Raises $37 Million in Series D Private Financing; Total to Be Raised Up nigel bates-8/24/2006
188I have them on my watch list but I don't own them. But I may soon if the makenhott-5/17/2006
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News